These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3326651)

  • 1. Acute monocytic leukemia in children. Response to VP-16-213 as a single agent.
    Nishikawa A; Nakamura Y; Nobori U; Aoki T; Higashino H; Matsui T; Kobayashi Y; Yamashita M; Unishi G
    Cancer; 1987 Nov; 60(9):2146-9. PubMed ID: 3326651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VP 16-213 and cyclophosphamide in the treatment of refractory acute nonlymphocytic leukemia with monocytic features.
    Hurd DD; Peterson BA; McKenna RW; Bloomfield CD
    Med Pediatr Oncol; 1981; 9(3):251-5. PubMed ID: 7017368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [VP 16-213 in the treatment of acute leukemia in childhood].
    Esumi N; Arakawa S; Imashuku S
    Gan To Kagaku Ryoho; 1983 Mar; 10(3):848-51. PubMed ID: 6576730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epipodophyllotoxin-related leukemia. Identification of a new subset of secondary leukemia.
    Whitlock JA; Greer JP; Lukens JN
    Cancer; 1991 Aug; 68(3):600-4. PubMed ID: 1648435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Initial results with a epipodophyllotoxin derivative VP 16-213 in the treatment of acute leukemia].
    Cavalli F; Ryssel HJ; Batz K; Sonntag RW; Brunner KW
    Schweiz Med Wochenschr; 1975 Feb; 105(8):250-3. PubMed ID: 1054886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Etoposide in remission induction of adult acute myeloid leukemia.
    Leoni F; Ciolli S; Patriarchi S; Morfini M; Rossi Ferrini P
    Acta Haematol; 1990; 83(2):82-5. PubMed ID: 2106200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparative evaluation of a combination of daunorubicin and cytosine arabinoside and that of aclarubicin and cytosine arabinoside in remission induction in acute non-lymphocytic leukemia].
    Takahashi I; Hara M; Ohmoto E; Oda Y; Endo Y; Fujimoto S; Uchida K; Takaoka K; Watanabe S; Lai M; Kohi F; Kitajima K; Kimura I; Sanada H; Tokioka M; Adachi T; Yorimitsu S
    Gan To Kagaku Ryoho; 1982 Sep; 9(9):1617-22. PubMed ID: 6964050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Etoposide (VP 16/NK 171) and cytosine arabinoside combination chemotherapy in refractory childhood leukemia].
    Esumi N; Todo S; Arakawa S; Imashuku S
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):951-8. PubMed ID: 3963859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose VP 16-213 (NSC 141540) for the treatment of patients with previously treated acute leukemia.
    Van Echo DA; Wiernik PH; Aisner J
    Cancer Clin Trials; 1980; 3(4):325-8. PubMed ID: 6933027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vinblastine, 5-azacytidine, and VP-16-213 therapy for previously treated patients with acute nonlymphocytic leukemia.
    Van Echo DA; Lichtenfeld KM; Wiernik PH
    Cancer Treat Rep; 1977 Nov; 61(8):1599-602. PubMed ID: 72605
    [No Abstract]   [Full Text] [Related]  

  • 11. [Long-term oral administration of etoposide (VP-16) for the patients with refractory or relapsed acute non-lymphocytic leukemia].
    Koyama S; Saitou H; Kashiwaba M
    Rinsho Ketsueki; 1991 Jul; 32(7):736-42. PubMed ID: 1920837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secondary acute myeloid leukemia in children with acute lymphoblastic leukemia treated with etoposide.
    Winick NJ; McKenna RW; Shuster JJ; Schneider NR; Borowitz MJ; Bowman WP; Jacaruso D; Kamen BA; Buchanan GR
    J Clin Oncol; 1993 Feb; 11(2):209-17. PubMed ID: 8426196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early intensification of chemotherapy for childhood acute nonlymphoblastic leukemia: improved remission induction with a five-drug regimen including etoposide.
    Kalwinsky D; Mirro J; Schell M; Behm F; Mason C; Dahl GV
    J Clin Oncol; 1988 Jul; 6(7):1134-43. PubMed ID: 3292713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple complete remissions over a period of 6 years in a patient with acute myeloid leukemia after intensive chemotherapy.
    Tsabouri S; Alimara V; Tsiara S; Vassiou A; Bourantas KL
    Leuk Lymphoma; 2007 Jan; 48(1):187-9. PubMed ID: 17325865
    [No Abstract]   [Full Text] [Related]  

  • 15. Acute monoblastic leukemia in infancy and early childhood: successful treatment with an epipodophyllotoxin.
    Odom LF; Gordon EM
    Blood; 1984 Oct; 64(4):875-82. PubMed ID: 6592009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anthracycline cardiomyopathy in children: report of two cases.
    Mosijczuk AD; Ruymann FB; Mease AD; Bernier RD
    Cancer; 1979 Nov; 44(5):1582-7. PubMed ID: 291472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Etoposide: fifteen years experience.
    Bernasconi C
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():52-5. PubMed ID: 2653518
    [No Abstract]   [Full Text] [Related]  

  • 18. Flow cytometric analysis of the cell cycle of the leukemic cell lines treated with etoposide and cytosine arabinoside.
    Ishiyama K; Satoh S; Igarashi Y; Kumagai H; Yahagi A; Sasaki H
    Tohoku J Exp Med; 1994 Oct; 174(2):95-107. PubMed ID: 7900157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclophosphamide/etoposide: effective reinduction therapy for children with acute nonlymphocytic leukemia in relapse.
    Kalwinsky DK; Dahl GV; Mirro J; Look AT
    Cancer Treat Rep; 1985; 69(7-8):887-9. PubMed ID: 4016796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Idarubicin in combination with intermediate-dose cytarabine and VP-16 in the treatment of refractory or rapidly relapsed patients with acute myeloid leukemia. The GIMEMA Cooperative Group.
    Carella AM; Carlier P; Pungolino E; Resegotti L; Liso V; Stasi R; Montillo M; Iacopino P; Mirto S; Pagano L
    Leukemia; 1993 Feb; 7(2):196-9. PubMed ID: 8426473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.